European Medicines Agency , London, UK
Nov 7 2011 8:00AM - 5:15PM
The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance
(ENCePP) is a project led by the European Medicines Agency (EMA) to bring together the
available expertise and research experience in the fields of pharmacoepidemiology and
pharmacovigilance across Europe in a Network of Excellence. There are now over 100 partners
registered in ENCePP including academic research and medical-care centres, healthcare
databases, electronic registries and existing networks. The details of all these partners are
public and are readily accessible to all parties with an interest in post-authorisation medicines
research in the fully searchable ENCePP Research Resources Database.
The aim of the ENCePP project is to further strengthen post-authorisation medicines research
in Europe by facilitating the conduct of high quality, multicentre, independent studies
focusing on safety and benefit risk. To encourage this, ENCePP has developed the concept
of an ‘ENCePP Study’, which is any pharmacoepidemiology or pharmacovigilance study that
fulfils a number of requirements in terms of transparency, independence and methodological
standards and is carried out in collaboration with an ENCePP partner.
In addition, ENCePP has launched an electronic Register of Studies which provides a
free and publicly accessible site for the registration of all pharmacoepidemiological and
pharmacovigilance studies, including non-interventional studies and clinical trials. Event Code:
11118
|
|